This was the stock's second consecutive day of losses.
The stock's fall snapped a two-day winning streak.
BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting ...
Fintel reports that on January 6, 2025, B of A Securities upgraded their outlook for Henry Schein (NasdaqGS:HSIC) from ...
Dental and medical professionals who may experience operational, logistical, or financial issues are encouraged to call 800-999-9729 ...
Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic ...
Some firms are maintaining hybrid work-life balance models amid a push for full-time return to the office from some major ...
As previously reported, BofA analyst Allen Lutz upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69, ...
Bank of America upgraded shares of Henry Schein (NASDAQ:HSIC – Free Report) from an underperform rating to a buy rating in a research report sent to investors on Monday, MarketBeat.com reports. Bank ...
BofA upgraded Henry Schein (HSIC) to Buy from Underperform with an $84 price target Don't Miss Our New Year's Offers:Discover the latest stocks ...